Navigation Links
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Date:8/28/2007

ss than $35 million, compared to original guidance estimates of approximately $40 million. Sunesis expects its 2008 cash used in operating activities to be at or below its 2007 level.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

Safe Harbor Statement

This press release contains forward-looking statements including without limitation statements related to the safety and potential efficacy of SNS-595, SNS-032 and SNS-314, planned additional clinical testing and development efforts, the anticipated timing of the commencement and completion of clinical trials and the announcement of clinical results, whether any future trial will constitute a registration trial sufficient to support an application for regulatory approval, potential corporate partnerships or collaborations, plans to strategically invest in drug discovery efforts, ability to advance high-quality lead candidates into preclinical and clinical development, the estimated reduction in Sunesis' operating expenses, the estimated restructuring charges to be incurred in the third quarter, and Sunesis' ongoing cash requirements . Words such as "anticipates," "plans," "will," "optimistic," "is expected" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), ... and Mr. David Pendarvis to its board of ... ,, Kenneth F. Buechler, Ph.D., was president, chief ... 1988 to 1994, Dr. Buechler was Biosite,s director ... was a senior research scientist for the diagnostics ...
(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...
(Date:12/16/2009)... introduces HSP-A Soy Peptone. HSP A has been found to ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ... Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), ... improve growth rates and yields. HSP-A has been found to ...
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
Breaking Biology Technology:Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... of improving business processes with enterprise-centric Internet tools is hardly ... of adoption means that reluctant business leaders need an education ... hardly be attributed to a lack of information. Building on ... Web 2.0? " bloggers like Dion Hinchcliffe , ...
... growing belief that whenever a state company is acquired by ... the state's economy. But the recent acquisition of Madison's ... . has a real chance to benefit both parties and ... ,The win-win view not only was offered by executives in ...
... - Five University of Wisconsin-Madison faculty have ... the National Academies . , ,Election to the National ... , the National Academy of Engineering , the ... - is considered one of the highest honors accorded ...
Other Biology Technology:Businesses are slow to adopt Web 2.0 concepts 2Businesses are slow to adopt Web 2.0 concepts 3Businesses are slow to adopt Web 2.0 concepts 4Anatomy of a deal: CDW and Berbee 2Anatomy of a deal: CDW and Berbee 3Anatomy of a deal: CDW and Berbee 4
(Date:12/16/2009)... December 15, 2009 Signal Hill, CA Tom ... public and president of Bowman Global Change, has developed ... the fourth Intergovernmental Panel on Climate Change (IPCC) report ... to the authentic scientific information they need to make ... Bowman created the new format as a means to ...
(Date:12/16/2009)... NEW YORK, Dec. 1 iQor, a global ... in the 2009 InfoWorld 100 Awards Top ... system, TeQ21. This was the first submission for iQor. ... prestigious list of companies," said Vikas Kapoor, president and ... we do business, allowing us to work faster, smarter ...
(Date:12/16/2009)... Dec. 2 DigitalPersona, Inc., a ... today announced an agreement with IBM to ... biometric fingerprint technology on IBM SurePOS 500 ... allows point-of-sale applications to more easily and ... can be linked to the individuals who ...
Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 1Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 3Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 4Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 5Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 1Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 2Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 3Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 5Test Before Corneal Transplant May Improve Outcome 50548 1Test Before Corneal Transplant May Improve Outcome 50548 2
... developed the first small molecule that can reversibly activate ... the way for drugs that can treat low blood ... sodium channel (ENaC) controls sodium flow across many tissues ... is vital to maintaining proper salt balance and blood ...
... Lanka are three times more likely to suffer from ... ethnic Norwegians. This finding comes from the Norwegian Institute ... registered in the Medical Birth Registry of Norway over ... that 90 percent of pregnant women experience some degree ...
... Cancer Conference, jointly organized by the European Society for ... Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight ... development of lung cancer. , Experts agree that ... contributes to lung cancer development. But other factors can ...
Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2Viruses may play a role in lung cancer development 2